Schulman Bhattacharya secured an important victory for its clients, two leading biotechnology entrepreneurs, in the United States District Court for the District of Massachusetts, which granted the Firm’s motion to dismiss the plaintiffs’ complaint in its entirety. The seven-count complaint had alleged federal and state securities fraud and related claims in connection with investments the plaintiffs made through a series of convertible promissory notes. The Firm’s clients vehemently denied any wrongdoing and were poised to vigorously contest the complaint on the merits. The Firm filed its motion to dismiss the plaintiff’s case on procedural grounds on February 13, 2025. Judge Richard G. Sterns granted the Firm’s motion to dismiss on March 3, 2025, even before a reply brief could be filed, finding that the “the court disagrees” with the plaintiffs’ arguments and that a forum selection clause negotiated by related parties conclusively barred the plaintiffs’ lawsuit in Massachusetts federal court.
Schulman Bhattacharya is an international law firm based in the Washington, D.C. area focused on resolving the most complex and challenging commercial disputes facing its clients— through litigation, arbitration, mediation, and informal negotiation. The Firm’s attorneys have vast experience representing clients in nearly every industry sector. The Firm represents companies of all sizes, locally, regionally, nationally, and internationally, and it represents individuals with valuable commercial and personal interests to protect. The national litigation team handling the Massachusetts litigation included Jeremy W. Schulman, Koushik Bhattacharya, and Renan Varghese.
Comments are closed.